Regeneron Pharmaceuticals
REGN
#228
Rank
A$125.40 B
Marketcap
$1,141
Share price
-0.17%
Change (1 day)
-6.56%
Change (1 year)

Earnings for Regeneron Pharmaceuticals (REGN)

Earnings in 2024 (TTM): A$7.35 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings are A$13.84 Billion. In 2023 the company made an earning of A$6.44 Billion a decrease over its 2022 earnings that were of A$7.45 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regeneron Pharmaceuticals from 1990 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) A$7.35 B14.01%
2023 A$6.44 B-13.57%
2022 A$7.45 B-47.9%
2021 A$14.31 B144.75%
2020 A$5.84 B56.86%
2019 A$3.72 B-4.87%
2018 A$3.92 B22.86%
2017 A$3.19 B56.3%
2016 A$2.04 B8.55%
2015 A$1.88 B54.53%
2014 A$1.21 B11.14%
2013 A$1.09 B72.13%
2012 A$0.63 B-285.93%
2011 -A$0.35 Billion121.73%
2010 -A$0.16 Billion37.18%
2009 -A$0.12 Billion-14.6%
2008 -A$0.14 Billion-25.02%
2007 -A$0.18 Billion6.32%
2006 -A$0.17 Billion-186.52%
2005 A$0.19 B2103.7%
2004 A$8.66 M-105.66%
2003 -A$0.16 Billion-18.18%
2002 -A$0.19 Billion42.33%
2001 -A$0.14 Billion129.35%
2000 -A$57.36 Million51.87%
1999 -A$37.77 Million92.19%
1998 -A$19.66 Million66.23%
1997 -A$11.83 Million-55.49%
1996 -A$26.56 Million103.53%
1995 -A$13.05 Million-70.89%
1994 -A$44.83 Million-26.08%
1993 -A$60.65 Million114.67%
1992 -A$28.25 Million196.77%
1991 -A$9.52 Million87.88%
1990 -A$5.07 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$7.18 B-5.84%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.29 Billion-103.76%๐Ÿ‡บ๐Ÿ‡ธ USA
A$2.01 B-73.56%๐Ÿ‡บ๐Ÿ‡ธ USA
A$28.24 B 270.17%๐Ÿ‡บ๐Ÿ‡ธ USA
A$19.54 B 156.21%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$11.37 B 49.07%๐Ÿ‡ซ๐Ÿ‡ท France